Vifor Fresenius Medical Care Renal Pharma Ltd., 10% Owner at ChemoCentryx, Inc. (CCXI), sold 324,816 shares at $53.66 ($17.2M) on 2020-07-27, disclosed to the SEC on 2020-07-29.
Open-market sale of $17.2M CCXI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.17 | 23,446 | $1.2M | 7.2% |
| 2 | $53.17 | 23,446 | $1.2M | 7.2% |
| 3 | $53.66 | 10,790 | $579K | 3.4% |
| 4 | $53.66 | 10,790 | $579K | 3.4% |
| 5 | $53.38 | 33,370 | $1.8M | 10.4% |
| 6 | $53.38 | 33,370 |
| $1.8M |
| 10.4% |
| 7 | $54.18 | 6,790 | $368K | 2.1% |
| 8 | $54.18 | 6,790 | $368K | 2.1% |
| 9 | $51.51 | 9,328 | $480K | 2.8% |
| 10 | $51.51 | 9,328 | $480K | 2.8% |
| 11 | $52.69 | 76,321 | $4.0M | 23.4% |
| 12 | $52.69 | 76,321 | $4.0M | 23.4% |
| 13 | $53.15 | 2,363 | $126K | 0.7% |
| 14 | $53.15 | 2,363 | $126K | 0.7% |
| Total | $52.97 avg | 324,816 | $17.2M | 100% |
| Filing → |
| CCXI | SELL | 2020-07-13 | $28.5M | — | Filing → |